News-Medical.Net on MSN13d
Solascure enrols first patient in a next phase II clinical trial to advance Aurase Wound GelSOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...
Clinical Trials Arena on MSN12d
SolasCure initiates Phase II trial of chronic wound treatment gelUK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback